MX2008001643A - Metodo para conservar la funcion de celulas productoras de insulina. - Google Patents

Metodo para conservar la funcion de celulas productoras de insulina.

Info

Publication number
MX2008001643A
MX2008001643A MX2008001643A MX2008001643A MX2008001643A MX 2008001643 A MX2008001643 A MX 2008001643A MX 2008001643 A MX2008001643 A MX 2008001643A MX 2008001643 A MX2008001643 A MX 2008001643A MX 2008001643 A MX2008001643 A MX 2008001643A
Authority
MX
Mexico
Prior art keywords
insulin
producing cells
preserving
function
furthering
Prior art date
Application number
MX2008001643A
Other languages
English (en)
Spanish (es)
Inventor
Wayman Wendell Cheatham
David C Diamond
Anders Hasager Boss
Original Assignee
Mannkind Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mannkind Corp filed Critical Mannkind Corp
Publication of MX2008001643A publication Critical patent/MX2008001643A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MX2008001643A 2005-08-01 2006-08-01 Metodo para conservar la funcion de celulas productoras de insulina. MX2008001643A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70429505P 2005-08-01 2005-08-01
PCT/US2006/030014 WO2007016600A2 (en) 2005-08-01 2006-08-01 Method of preserving the function of insulin-producing cells

Publications (1)

Publication Number Publication Date
MX2008001643A true MX2008001643A (es) 2008-04-07

Family

ID=37561086

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008001643A MX2008001643A (es) 2005-08-01 2006-08-01 Metodo para conservar la funcion de celulas productoras de insulina.

Country Status (10)

Country Link
EP (1) EP1915171B1 (https=)
JP (2) JP2009503093A (https=)
CN (1) CN101232899A (https=)
AU (1) AU2006275424B2 (https=)
BR (1) BRPI0614489A2 (https=)
CA (1) CA2617226A1 (https=)
DK (1) DK1915171T3 (https=)
ES (1) ES2439455T3 (https=)
MX (1) MX2008001643A (https=)
WO (1) WO2007016600A2 (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
US6923175B2 (en) 2002-03-20 2005-08-02 Mannkind Corporation Inhalation apparatus
ATE486064T1 (de) 2004-08-20 2010-11-15 Mannkind Corp Katalyse der diketopiperazinsynthese
KR20130066695A (ko) 2004-08-23 2013-06-20 맨카인드 코포레이션 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
MX373000B (es) 2005-09-14 2020-05-21 Mannkind Corp Metodo para formulacion de farmaco basado en el aumento de la afinidad de agentes activos hacia las superficies de microparticulas cristalinas.
EP1986679B1 (en) 2006-02-22 2017-10-25 MannKind Corporation A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
CN101827626B (zh) 2008-06-13 2015-03-18 曼金德公司 干粉吸入器和用于药物输送的系统
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
ES2421385T3 (es) 2008-06-20 2013-09-02 Mannkind Corp Aparato interactivo y procedimiento para establecer el perfil, en tiempo real, de esfuerzos de inhalación
TWI532497B (zh) 2008-08-11 2016-05-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
DK2379100T3 (en) * 2009-01-08 2014-12-01 Mannkind Corp Treatment of hyperglycemia with GLP-1
CN102438602B (zh) * 2009-03-04 2016-04-13 曼金德公司 改进的干燥粉末药物输送系统
DK2405963T3 (da) 2009-03-11 2013-12-16 Mannkind Corp Apparat, system og fremgangsmåde til at måle modstand i en inhalator
KR102584844B1 (ko) 2009-06-12 2023-10-04 맨카인드 코포레이션 한정된 비표면적을 갖는 디케토피페라진 마이크로입자
CA2778698A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
CN102985125A (zh) 2010-06-21 2013-03-20 曼金德公司 干粉药物输送系统和方法
SG194034A1 (en) 2011-04-01 2013-11-29 Mannkind Corp Blister package for pharmaceutical cartridges
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
MX2014004983A (es) 2011-10-24 2014-09-22 Mannkid Corp Metodos y composiciones para tratar dolor.
KR102264177B1 (ko) 2012-07-12 2021-06-11 맨카인드 코포레이션 건조 분말 약물 전달 시스템 및 방법
US9171343B1 (en) 2012-09-11 2015-10-27 Aseko, Inc. Means and method for improved glycemic control for diabetic patients
US9897565B1 (en) 2012-09-11 2018-02-20 Aseko, Inc. System and method for optimizing insulin dosages for diabetic subjects
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
EP3587404B1 (en) 2013-03-15 2022-07-13 MannKind Corporation Microcrystalline diketopiperazine compositions, methods for preparation and use thereof
MX375448B (es) 2013-07-18 2025-03-06 Mannkind Corp Composiciones farmacéuticas en polvo seco estables al calor y métodos.
EP3030294B1 (en) 2013-08-05 2020-10-07 MannKind Corporation Insufflation apparatus
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
US9898585B2 (en) 2014-01-31 2018-02-20 Aseko, Inc. Method and system for insulin management
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
EP3933845A3 (en) 2014-10-27 2022-06-22 Aseko, Inc. Subcutaneous outpatient management
US11081226B2 (en) 2014-10-27 2021-08-03 Aseko, Inc. Method and controller for administering recommended insulin dosages to a patient
JP7109155B2 (ja) 2015-06-04 2022-07-29 キッコーマン株式会社 フラビン結合型グルコースデヒドロゲナーゼを用いたグルコースの測定方法
EP3337402B1 (en) 2015-08-20 2026-01-07 Glytec, LLC Diabetes management therapy advisor
CN110187123B (zh) * 2019-05-06 2022-07-22 天津医科大学总医院 一种糖尿病早期诊断生物标志物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1259045A (zh) * 1997-04-02 2000-07-05 普渡研究基金会 蛋白质的口服释放方法
ES2569916T3 (es) * 1999-06-29 2016-05-13 Mannkind Corporation Formulaciones farmacéuticas que comprenden insulina complejada con una dicetopiperazina
GB0217382D0 (en) * 2002-07-26 2002-09-04 Pfizer Ltd Process for making orally consumable dosage forms
WO2004080401A2 (en) * 2003-03-06 2004-09-23 Emisphere Technologies, Inc. Oral insulin therapies and protocol
ES2584867T3 (es) * 2004-01-12 2016-09-29 Mannkind Corporation Un método que reduce los niveles séricos de proinsulina en diabéticos de tipo 2

Also Published As

Publication number Publication date
JP2009503093A (ja) 2009-01-29
BRPI0614489A2 (pt) 2011-03-29
WO2007016600A3 (en) 2007-05-31
AU2006275424B2 (en) 2013-01-10
CA2617226A1 (en) 2007-02-08
CN101232899A (zh) 2008-07-30
EP1915171B1 (en) 2013-11-20
DK1915171T3 (da) 2013-12-09
JP2015091854A (ja) 2015-05-14
EP1915171A2 (en) 2008-04-30
ES2439455T3 (es) 2014-01-23
AU2006275424A1 (en) 2007-02-08
WO2007016600A2 (en) 2007-02-08

Similar Documents

Publication Publication Date Title
MX2008001643A (es) Metodo para conservar la funcion de celulas productoras de insulina.
WO2007095594A3 (en) Methods and compositions for enhancing engraftment of hematopoietic stem cells
DK2321321T3 (da) Triazolo [4,5-d]pyramidinderivater og anvendelse deraf som purinreceptorantagonister
NZ595706A (en) L-ornithine phenyl acetate and methods of making thereof
EP2705850A3 (en) Super fast-acting insulin compositions
IL189555A0 (en) Compositions of cells enriched for combinations of various stem and progenitor cell populations, methods of use thereof and methods of private banking thereof
IL194438A (en) Diarrhylthiohydantoin Compounds, Pharmaceuticals Containing Them, Syntheses Methods and In Vitro Methods for Contacting them with Mammalian Cells
WO2008036374A3 (en) Allogeneic stem cell transplants in non-conditioned recipients
WO2008003007A3 (en) Compositions and methods for treating parasitic infections
EP2727998A3 (en) Methods for purifying pancreatic endoderm cells derived from human embryonic stem cells
TW200714590A (en) Heterocyclic inhibitors of MEK and methods of use thereof
WO2008001240A3 (en) Transdermal delivery of oleocanthal for relief of inflammation
MX2008006589A (es) Composiciones de edulcorante natural de mesa, de alta potencia, con perfil temporal y/o de sabor mejorado, metodos para su formulacion, y usos
MX348735B (es) Celulas madre mesenquimales que expresan los receptores tnf-alfa.
WO2006017134A3 (en) Preprimitive streak and mesendoderm cells
WO2009086471A3 (en) Synergistic antiparasitic compositions and screening methods
WO2008016730A3 (en) Compositions and methods for reducing cellular fat
BRPI0506839A (pt) composições e métodos para induzir a cardiomiogênese
SG148171A1 (en) Methods of proliferating stem cells
ITTO20040390A1 (it) Composizione, in particolare per uso farmaceutico, ad azione antiossidante, antinfiammatoria ed immunostimolante.
EA200701029A1 (ru) Новая композиция для облегчения человеческих родов
IL205696A0 (en) Heterocyclic derivatives, compositions comprising the same and uses thereof
CR9853A (es) Compuestos de exemestano (s)-6-metiloxaalquilo y metodos relacionados con su utilizacion
WO2011029102A3 (en) Cd117+cells and uses thereof
WO2011019867A3 (en) Dietary supplements and methods for treating pain and inflammation

Legal Events

Date Code Title Description
FA Abandonment or withdrawal